ReviewFrontiers in immunology2026
Antibody-drug conjugates in recurrent or metastatic HNSCC: relevant targets, clinical development, and future prospects.
Hu Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it